Immunofluorescence staining revealed that the expression of bone morphogenetic protein 2 (BMP-2), a key osteogenic marker, was significantly upregulated in the mice with CAVD (Fig. 2g, h). This evidence concerns the gene BMP2 and congenital bilateral aplasia of vas deferens from CFTR mutation.